An ayurvedic management of chronic prostatitis

A study on management of chronic prostatitis by basti therapy - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083739

Enrollment

Registered

2025-03-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N411- Chronic prostatitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age between 20-40yrs All cases of chronic prostatitis /Chronic pelvic pain syndrome Diagnosed cases of sexual dysfunction i.e. ejaculatory pain, erectile dysfunction, premature ejaculation. Patients willing to participate in the study

Exclusion criteria

Exclusion criteria: Acute prostatitis Prostatic abscess Pyuria Chronic HTN T2DM Known cases of Systemic disease like Tuberculosis, HepatitisB, HIV, Hepatitis C, Cardiac diseases, Uncontrolled DM Neurogenic bladder Carcinoma of prostate Subjects with ARF&CRF Subjects with Veneral diseases Urethral stricture

Design outcomes

Primary

Measure	Time frame
Disease specific subjective parameters based on NIH CPSI score and IIEF 5 Scoring. Objective parameters based on radiological findings (USG,TRUS, Multiparametric MRI) and biochemical analysis(Serum PSA and Serum Testosterone) inflammation of prostate will be assessed.Timepoint: Basti will be administered for a period of 15 days followed by follow up at 15 days , 1 month and 2 months .	—

Secondary

Measure	Time frame
Relief in signs and symptoms of chronic prostatitis Timepoint: For a period of 3 months	—

Countries

India

Contacts

Public ContactDr Rohit Kumar Yadav

Banaras Hindu University

drarunbhu@gmail.com9451050860

Outcome results